J3 BIOSCIENCE, INC.

SALT LAKE CITY, UT · Medtech · Private

LIV-Ring platform for long-acting contraceptive and women's health vaginal rings with controlled drug delivery

Claim this profile

Follows are private to you and power your alerts

Updated · j3bio.com

Sector
Medtech
Headquarters
SALT LAKE CITY, UT
Latest Form D
$50K, Oct 2026
Total capital
$3.5M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$3.5M
12 Form D · last Oct 2026
0 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
None on recordNo USPTO grants. Applications publish after 18 months.

Capital timeline

20122014201620182020202220242026FEDERAL ↑EQUITY ↓Cumulative $3.5M2nd Form D$1.1M
2012201620202024FEDERAL ↑EQUITY ↓Cumulative $3.5M

Latest events

  • Private capital raisedForm D · SEC · 12th filing$50K
  • Private capital raisedForm D · SEC · 11th filing$20K
  • Private capital raisedForm D · SEC · 10th filing$50K
  • Private capital raisedForm D · SEC · 9th filing$20K
  • Private capital raisedForm D · SEC · 8th filing$530K
  • Private capital raisedForm D · SEC · 7th filing$605K
  • Private capital raisedForm D · SEC · 6th filing$20K
  • Private capital raisedForm D · SEC · 5th filing$23K
  • Private capital raisedForm D · SEC · 4th filing$350K
  • Private capital raisedForm D · SEC · 3rd filing$215K
  • Private capital raisedForm D · SEC · 2nd filing$1.1M
  • Private capital raisedForm D · SEC · 1st filing$541K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Founders and team

From SEC Form D filings
  • Duck Joo LeeDirectorNamed in SEC Form D filings
  • Jayne F. CarneyDirectorNamed in SEC Form D filings
  • John S. FairExecutive Officer, DirectorNamed in SEC Form D filings
  • Keith A. MarmerDirectorNamed in SEC Form D filings
  • Larry D. RigbyDirectorNamed in SEC Form D filings
  • R. Tyler McCabeExecutive Officer, DirectorNamed in SEC Form D filings
Show all 12 people
  • Ron E. NielsenDirectorNamed in SEC Form D filings
  • Sheryl A. KingsbergDirectorNamed in SEC Form D filings
  • Stath J. KarrasDirectorNamed in SEC Form D filings
  • Stephanie A. SingerDirectorNamed in SEC Form D filings
  • Tim S. GlassettExecutive Officer, DirectorNamed in SEC Form D filings
  • Troy E. MasonDirectorNamed in SEC Form D filings

What it has protected

No granted patents are on record.

USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.

Checked: USPTO granted patents and published applications · Oct 23, 2026

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .